Patents by Inventor Yatindra Joshi

Yatindra Joshi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DEUTERATED RUC-4
    Publication number: 20230364094
    Abstract: Provided herein are deuterated RUC-4 compounds, and related compositions and therapeutic methods.
    Type: Application
    Filed: April 27, 2023
    Publication date: November 16, 2023
    Applicant: CeleCor Therapeutics, Inc.
    Inventor: Yatindra Joshi
  • Deuterated RUC-4
    Patent number: 11684622
    Abstract: Provided herein are deuterated RUC-4 compounds, and related compositions and therapeutic methods.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: June 27, 2023
    Assignee: CeleCor Therapeutics, Inc.
    Inventor: Yatindra Joshi
  • DEUTERATED RUC-4
    Publication number: 20210361658
    Abstract: Provided herein are deuterated RUC-4 compounds, and related compositions and therapeutic methods.
    Type: Application
    Filed: June 18, 2019
    Publication date: November 25, 2021
    Applicant: CeleCor Therapeutics, Inc.
    Inventor: Yatindra Joshi
  • Formulation
    Publication number: 20140287040
    Abstract: This invention relates to a formulation comprising a dipeptidylpeptidase IV (DPP-IV) inhibitor preferably vildagliptin and metformin, to tablets comprising such formulations and to processes for the preparation thereof.
    Type: Application
    Filed: June 5, 2014
    Publication date: September 25, 2014
    Applicant: Novartis AG
    Inventors: Yatindra Joshi, James Kowalski, Jay Parthiban Lakshman, Alan Edward Royce, Wei-Qin Tong, Madhav Vasanthavada
  • Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same
    Patent number: 8475839
    Abstract: Monolayer, bilayer and trilayer solid dosage forms of a combination of valsartan, amlodipine and hydrochlorothiazide are made.
    Type: Grant
    Filed: January 3, 2012
    Date of Patent: July 2, 2013
    Assignee: Novartis AG
    Inventors: Yu Cao, Yatindra Joshi, Ping Li, Madhusudhan Pudipeddi, Alan E Royce, Robert F Wagner, Jiahao Zhu
  • Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same
    Patent number: 8435563
    Abstract: Monolayer, bilayer and trilayer solid dosage forms of a combination of valsartan, amlodipine and hydrochlorothiazide are made.
    Type: Grant
    Filed: January 3, 2012
    Date of Patent: May 7, 2013
    Assignee: Novartis Pharmaceuticals Corporation
    Inventors: Yu Cao, Yatindra Joshi, Ping Li, Madhusudhan Pudipeddi, Alan E Royce, Robert F Wagner, Jiahao Zhu
  • Oral administration of a calcitonin
    Patent number: 8410052
    Abstract: The invention is directed to a method of administering pharmaceutical compositions comprising peptide drugs such as a calcitonin in combination with one or more oral delivery agents, together with an amount of a liquid, and method of treatment of disorders responsive to the action of peptide drugs such as a calcitonin employing such method of administration so as to enhance the oral bioavailability of a calcitonin. The methods of the invention increase the oral absorption and systemic bioavailability of peptide drugs, such as a calcitonin.
    Type: Grant
    Filed: February 29, 2008
    Date of Patent: April 2, 2013
    Assignee: Novartis AG
    Inventor: Yatindra Joshi
  • Formulation
    Publication number: 20130052239
    Abstract: This invention relates to a formulation comprising a dipeptidylpeptidase IV (DPP-IV) inhibitor preferably vildagliptin and metformin, to tablets comprising such formulations and to processes for the preparation thereof.
    Type: Application
    Filed: September 4, 2012
    Publication date: February 28, 2013
    Inventors: Yatindra Joshi, James Kowalski, Jay Parthiban Lakshman, Alan Edward Royce, Wei-Qin Tong, Madhav Vasanthavada
  • Pharmaceutical compositions comprising hGH for oral delivery
    Patent number: 8323688
    Abstract: The present invention relates to dosage forms of human growth hormone, the use of an absorption enhancer to allow absorption of human growth hormone into the systemic circulation in a biologically active form, in particular after oral administration, as well as the use of oral dosage forms comprising human growth hormone and an absorption enhancer for the treatment of human growth hormone deficiencies and disorders associated therewith.
    Type: Grant
    Filed: August 28, 2007
    Date of Patent: December 4, 2012
    Assignee: Novartis AG
    Inventors: Moise Azria, Yatindra Joshi, Rosario Lobrutto, Linda Mindeholm, Ashish B Patel
  • SOLID DOSAGE FORMS OF VALSARTAN AND AMLODIPINE AND METHOD OF MAKING THE SAME
    Publication number: 20120177733
    Abstract: Monolayer and bilayer solid dosage forms of a combination of valsartan and amlodipine are made.
    Type: Application
    Filed: February 23, 2012
    Publication date: July 12, 2012
    Inventors: Yatindra Joshi, Robert Frank Wagner, Madhusudhan Pudipeddi, Gangadhar Sunkara, Ping Li
  • SOLID DOSAGE FORMS OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE AND METHOD OF MAKING THE SAME
    Publication number: 20120164218
    Abstract: Monolayer, bilayer and trilayer solid dosage forms of a combination of valsartan, amlodipine and hydrochlorothiazide are made.
    Type: Application
    Filed: January 3, 2012
    Publication date: June 28, 2012
    Inventors: Yu Cao, Yatindra Joshi, Ping Li, Madhusudhan Pudipeddi, Alan Edward Royce, Robert Frank Wagner, Jiahao Zhu
  • Process for making compositions with poorly compressible therapeutic compounds
    Publication number: 20120077879
    Abstract: A process for preparing solid dosage forms that contain poorly compressible therapeutic compound. The process, for example, provides for the inventive use of an extruder, especially a twin screw extruder, to melt granulate a therapeutic compound(s) with a granulation excipient.
    Type: Application
    Filed: November 30, 2011
    Publication date: March 29, 2012
    Inventors: Madhav Vasanthavada, Jay Lakshman, Wei-Qin Tong, Abu T. M. Serajuddin, Yatindra Joshi, James Kowalski
  • MODIFIED RELEASE 1- [ (3-HYDROXY-ADAMANT-1-YLAMINO)-ACETYL] -PYRROLIDINE-2 (S) -CARBONITRILE FORMULATION
    Publication number: 20110086096
    Abstract: The subject invention provides a pharmaceutical tablet formulation comprising per unit dosage form e.g.
    Type: Application
    Filed: December 15, 2010
    Publication date: April 14, 2011
    Inventors: JAMES KOWALSKI, JAN PARTHIBAN LAKSHMAN, ABU T. SERAJUDDIN, YATINDRA JOSHI
  • FORMULATION
    Publication number: 20110045062
    Abstract: This invention relates to a formulation comprising a dipeptidylpeptidase IV (DPP-IV) inhibitor preferably vildagliptin and metformin, to tablets comprising such formulations and to processes for the preparation thereof.
    Type: Application
    Filed: November 4, 2010
    Publication date: February 24, 2011
    Inventors: Yatindra Joshi, James Kowalski, Jay Parthiban Lakshman, Alan Edward Royce, Wei-Qin Tong, Madhav Vasanthavada
  • SOLID DOSAGE FORMS OF VALSARTAN AND AMLODIPINE AND METHOD OF MAKING SAME
    Publication number: 20100303906
    Abstract: Monolayer and bilayer solid dosage forms of a combination of valsartan and amlodipine are made.
    Type: Application
    Filed: August 9, 2010
    Publication date: December 2, 2010
    Inventors: Yatindra Joshi, Robert Frank Wagner, Madhusudhan Pudipeddi, Gangadhar Sunkara, Ping Li
  • PHARMACEUTICAL COMPOSITIONS COMPRISING HGH FOR ORAL DELIVERY
    Publication number: 20100247608
    Abstract: The present invention relates to dosage forms of human growth hormone, the use of an absorption enhancer to allow absorption of human growth hormone into the systemic circulation in a biologically active form, in particular after oral administration, as well as the use of oral dosage forms comprising human growth hormone and an absorption enhancer for the treatment of human growth hormone deficiencies and disorders associated therewith.
    Type: Application
    Filed: August 28, 2007
    Publication date: September 30, 2010
    Inventors: Moise Azria, Yatindra Joshi, Rosario Lobrutto, Linda Mindeholm, Ashish B. Patel
  • ORAL ADMINISTRATION OF A CALCITONIN
    Publication number: 20100210526
    Abstract: The invention is directed to a method of administering pharmaceutical compositions comprising peptide drugs such as a calcitonin in combination with one or more oral delivery agents, together with an amount of a liquid, and method of treatment of disorders responsive to the action of peptide drugs such as a calcitonin employing such method of administration so as to enhance the oral bioavailability of a calcitonin. The methods of the invention increase the oral absorption and systemic bioavailability of peptide drugs, such as a calcitonin.
    Type: Application
    Filed: February 29, 2008
    Publication date: August 19, 2010
    Inventor: Yatindra Joshi
  • Process for making compositions with poorly compressible therapeutic compounds
    Publication number: 20100152299
    Abstract: A process for preparing solid dosage forms that contain poorly compressible therapeutic compound. The process, for example, provides for the inventive use of an extruder, especially a twin screw extruder, to melt granulate a therapeutic compound(s) with a granulation excipient.
    Type: Application
    Filed: May 8, 2006
    Publication date: June 17, 2010
    Inventors: Madhav Vasanthavada, Jay Lakshman, Wein-Qin Tong, Abu T. Serajuddin, Yatindra Joshi, James Kowalsi
  • MICROEMULSION DOSAGE FORMS OF VALSARTAN AND METHODS OF MAKING THE SAME
    Publication number: 20100035949
    Abstract: A drug delivery system, e.g., microemulsion preconcentrate, that spontaneously forms a microemulsion when brought in contact with an aqueous medium. The drug delivery system contains valsartan, a hydrophilic component, a lipophilic component and a surfactant. A particularly useful hydrophilic component in the system is a polymer that is solid at room temperature, e.g., solid PEG.
    Type: Application
    Filed: December 3, 2007
    Publication date: February 11, 2010
    Inventors: Yatindra Joshi, John J. Kennedy, Ping Li, Alan E. Royce, Robert F. Wagner
  • Modified Release 1-[(3-Hydroxy-Adamant-1-Ylamino)-Acetyl]-Pyrrolidine-2(S)-Carbonitrile Formulation
    Publication number: 20100021539
    Abstract: The subject invention provides a pharmaceutical tablet formulation comprising per unit dosage form e.g.
    Type: Application
    Filed: June 8, 2006
    Publication date: January 28, 2010
    Inventors: James Kowalski, Jay P. Lakshman, Abu T. Serajuddin, Yatindra Joshi